Apyx Medical Study Shows Renuvion Boosts Liposuction Outcomes — Apyx Medical Corporation

Event summary

Retrospective study of 113 patients found Renuvion combined with liposuction improved skin quality satisfaction (87.8 vs. 73.8) and abdominal appearance satisfaction (68.8 vs. 45.0).
Abdominoplasty rates were 50% lower in Renuvion group (30.0% vs. 67.1%), with revision rates also significantly lower (12.0% vs. 37.5%).
Complication rates remained similar between groups (2.5% vs. 2.7%).
Study published in Plastic and Reconstructive Surgery - Global Open on May 14, 2026.

The big picture

The study adds to growing clinical evidence supporting Renuvion's role in aesthetic body contouring, potentially expanding its use in the $2.5 billion global liposuction market. With over 2 million procedures annually, any technology that improves outcomes and reduces revision rates could capture significant market share. The findings position Apyx Medical to compete more effectively against established players in surgical aesthetics.

What we're watching

Clinical Adoption: Whether the study results will accelerate surgeon adoption of Renuvion in combination with liposuction procedures.
Competitive Positioning: How Apyx Medical will leverage this data to differentiate AYON Body Contouring System in the competitive aesthetic surgery market.
Regulatory Pathways: The pace at which additional clinical evidence will be generated to support broader applications of Renuvion technology.